Stay updated with the latest cancer-cell news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on cancer-cell topics.
A major Chinese clinical study on ovarian cancer has been published in CA: A Cancer Journal for Clinicians, one of the world's highest-impact medical journal, marking a first for a Chinese researcher-led gynecological cancer trial, researchers said in Beijing on Sunday. The phase III FZOCUS-1 study tested fluzoparib, a PARP inhibitor developed by Chinese pharmaceutical giant Hengrui Pharma. The trial evaluated the drug as a "maintenance" therapy, treatment given to prevent cancer recurrence aft ...Read More >
The latest therapeutic cancer vaccines are designed to prevent cancer recurrence in patients who have already received treatment. These vaccines represent a form of immunotherapy that trains the immune system to target and destroy cancer cells. Experts emphasized the need for personalized treatment approaches in a rapidly evolving field. In a groundbreaking development, new therapeutic cancer vaccines have emerged, aimed at preventing the recurrence of cancer in treated patients, as explained b ...Read More >
Kochi, Sept 14: New cancer vaccines are being developed not to prevent the onset of cancer in healthy individuals but to stop its recurrence in those who have already undergone treatment, a medical expert has clarified. Speaking at the inaugural session of the second annual conference of the Gastrointestinal Oncology Society (GIOS) on Saturday, Dr Rajeev Jayadevan, convener of the Research Cell at Kerala State IMA and chairman of the scientific committee at IMA Cochin, explained that these are ...Read More >
Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.